LinkedIn Icon
May 4-6, 2020 | Boston, MA

Why 2019?

Non-Invasive Biomarkers Deep Dive

Join the full seminar day dedicated to benchmarking and sharing the most innovative case studies set to unlock the next arsenal of NASH candidates. Chaired by Jay Chuang (NASH, Fibrotic Diseases, Biomarker Sciences & Research Scientist at Gilead) this focused seminar benchmarks the very latest from NIMBLE, LITMUS and innovations within imaging and serum biomarkers to better inform your biomarker related strategies and support clinical program success.

Commercial Leaders Day

Hear from marketing and commercial development leads as they share perspectives on strategizing considerations for commercialization, navigating market development, and building investor confidence in the crowded NASH landscape. Be part of the discussions taking place (led by NICE and Payer’s Perspective Investor Perspective)within this exclusively commercial stream and map out the next step of your business development plan in NASH.K

Keynotes & Networking Evening

Join us for an evening of networking and NASH keynote speakers, including our inaugural patient insights panel (GLI, FLF and NASH Education). Establish connections early on, contextualize conversations before the main sessions or just relax and enjoy the atmosphere. We’re excited to host you all and celebrate the progress of drug development in the last 12 months.